ResMed Balance Sheet Health
Financial Health criteria checks 6/6
ResMed has a total shareholder equity of $4.5B and total debt of $1.2B, which brings its debt-to-equity ratio to 27.4%. Its total assets and total liabilities are $6.9B and $2.4B respectively. ResMed's EBIT is $1.2B making its interest coverage ratio 19.6. It has cash and short-term investments of $217.9M.
Key information
27.4%
Debt to equity ratio
US$1.23b
Debt
Interest coverage ratio | 19.6x |
Cash | US$217.86m |
Equity | US$4.48b |
Total liabilities | US$2.42b |
Total assets | US$6.91b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: R1MD34's short term assets ($2.4B) exceed its short term liabilities ($764.1M).
Long Term Liabilities: R1MD34's short term assets ($2.4B) exceed its long term liabilities ($1.7B).
Debt to Equity History and Analysis
Debt Level: R1MD34's net debt to equity ratio (22.5%) is considered satisfactory.
Reducing Debt: R1MD34's debt to equity ratio has reduced from 61.2% to 27.4% over the past 5 years.
Debt Coverage: R1MD34's debt is well covered by operating cash flow (88%).
Interest Coverage: R1MD34's interest payments on its debt are well covered by EBIT (19.6x coverage).